2/2
07:13 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
2/2
07:00 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
1/29
07:00 am
skye
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
Low
Report
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
1/21
07:00 am
skye
Skye Bioscience to Present Poster at Keystone Obesity Conference
Low
Report
Skye Bioscience to Present Poster at Keystone Obesity Conference
1/20
11:19 am
skye
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
1/19
02:13 am
skye
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Low
Report
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
1/19
02:04 am
skye
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
1/16
03:01 pm
skye
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
Low
Report
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
11/10/2025
04:01 pm
skye
skye bioscience, inc.
BEAT
Report
2.8%
skye bioscience, inc.
8/7/2025
04:01 pm
skye
skye bioscience, inc.
MISS
Report
-0.8%
skye bioscience, inc.
5/8/2025
04:01 pm
skye
skye bioscience, inc.
BEAT
Report
1.1%
skye bioscience, inc.
3/20/2025
04:01 pm
skye
skye bioscience, inc.
BEAT
Report
19.0%
skye bioscience, inc.
2/2
07:05 am
skye
Form 8-K Skye Bioscience, Inc. For: Feb 02
High
Report
Form 8-K Skye Bioscience, Inc. For: Feb 02
12/23
04:04 pm
skye
Form 8-K Skye Bioscience, Inc. For: Dec 18
Low
Report
Form 8-K Skye Bioscience, Inc. For: Dec 18
12/16
04:30 pm
skye
Form SCHEDULE 13D/A Skye Bioscience, Inc. Filed by: 5AM Partners VII, LLC
High
Report
Form SCHEDULE 13D/A Skye Bioscience, Inc. Filed by: 5AM Partners VII, LLC
11/10
04:10 pm
skye
Form 8-K Skye Bioscience, Inc. For: Nov 10
Low
Report
Form 8-K Skye Bioscience, Inc. For: Nov 10
11/10
04:09 pm
skye
Form 10-Q Skye Bioscience, Inc. For: Sep 30
Low
Report
Form 10-Q Skye Bioscience, Inc. For: Sep 30
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register